Skip to main content

December 2, 2020, TBDWG Meeting (online)

Tick-Borne Disease Working Group
December 2, 2020, TBDWG Meeting (online)

Back to Tick-Borne Disease Working Group Meetings

December 2, 2020

During this meeting, the TBDWG will finalize and vote on the 2020 Report to the HHS Secretary and Congress. This meeting is open to the public. An agenda will be provided prior to the meeting.

Federal Register Notice

Written Public Comments

Meeting Summary

Archived Webcast

If you would like the December 2, 2020, slide presentation, please send your request to tickbornedisease@hhs.gov.

Agenda

TimeMeeting ItemPresenter
9:00 am - 9:03 am

Welcome

  • Roll Call w/introductions

Jim Berger, DFO
9:03 am - 9:08 amRecap of Meeting #17
Review of Meeting #18 agenda and goals		Leigh Ann Soltysiak, Co-Chair
David Walker, Co-Chair
9:08 am - 9:10 amOverview of the Working Group's Mission, Vision Statement, ValuesJim Berger, DFO
9:10 am - 9:40 amPublic CommentLeigh Ann Soltysiak, Co-Chair
David Walker, Co-Chair
9:40 am - 10:00 amLyme X PresentationKristen Honey, HHS
10:00 am - 10:02 am

Executive Summary review

  • Chapter has already been approved with the editorial changes; we will just show that the changes were made

Working Group
10:02 am - 10:03 am

Chapter 1: Background

  • Chapter has already been approved with no changes; we will just show the chapter in the template again

Working Group
10:03 am - 10:04 am

Chapter 2: Methods

  • Chapter has already been approved with no changes; we will just show the chapter in the template again

Working Group
0:04 am - 10:06 am

Chapter 3: Tick Biology, Ecology, and Control Review in Template format

  • Chapter has already been approved with the editorial changes; we will just show that the changes were made

Kevin Macaluso
Beto Perez de Leon
10:06 am - 10:08 am

Chapter 4: Clinical Manifestations, Diagnosis, and Diagnostics Review in Template format

  • Chapter has already been approved with the editorial changes; we will just show that the changes were made

Sam Donta
Alt. FDA Rep, Todd Myers
10:08 am - 10:09am

Chapter 5: Causes, Pathogenesis, and Pathophysiology review in Template format

  • Chapter has already been approved with no changes; we will just show the chapter in the template again

Scott Commins
Angel Davey
10:09 am - 10:10 am

Chapter 6: Treatment review in Template format

  • Chapter has already been approved with the editorial changes; we will just show that the changes were made

Dennis Dixon
Sam Donta
10:10 am - 10:12 am

Chapter 7: Clinician and Public Education, Patient Access to Care review in Template format

  • Chapter has already been approved with the editorial changes; we will just show that the changes were made

Alt. CMS Rep, Scott Cooper
Pat Smith
10:12 am - 10:14 am

Chapter 8: Epidemiology and Surveillance review

  • Chapter has already been approved with the editorial changes; we will just show that the changes were made

Ben Beard
Gene Shapiro
10:14 am - 10:15 am

Chapter 9: Federal Inventory review

  • Chapter has already been approved with no changes; we will just show the chapter in the template again

Sam Donta
Pat Smith
David Walker
10:15 am - 10:17 am

Chapter 10: Public Input review

  • Chapter has already been approved with the editorial changes; we will just show that the changes were made

Scott Commins, Co-Chair
Angel Davey, Co-Chair
Leigh Ann Soltysiak, Co-Chair
10:17 am - 10:18 am

Chapter 11: Looking Forward - review in template

  • Chapter has already been approved with no changes; we will just show the chapter in the template again

Working Group
0:18 am - 10:20 am

Chapter 12: Conclusion review in template

  • Chapter has already been approved with the editorial changes; we will just show that the changes were made

Working Group
10:20 am - 10:25 amAppendices review in templateWorking Group
10:25 am - 10:30 amFront Cover, Table of Contents and Back Cover reviewWorking Group
10:30 am - 10:35 amReview of Meeting #18, Thank YouLeigh Ann Soltysiak, Co-Chair
David Walker, Co-Chair
10:35 amAdjournment 

Content created by Office of Infectious Disease and HIV/AIDS Policy (OIDP)
Content last reviewed February 9, 2021